{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:06:06Z","timestamp":1789664766558,"version":"4.0.1"},"reference-count":68,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Eur J Immunol"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Autoimmune diseases arise from a breakdown in immune tolerance. This leads to self\u2010reactive immune responses and chronic inflammation. Induction of antigen\u2010specific tolerance offers a targeted approach that restores immune balance without global immunosuppression. We discuss current approaches to therapies that seek to induce tolerance. These include peptide\u2010, immunoglobulin\u2010, carrier\u2010, and cell\u2010based approaches. We review clinical trials and preclinical studies that explore novel strategies for the induction of durable (antigen\u2010specific) tolerance as possible interventions in autoimmune disease.<\/jats:p>","DOI":"10.1002\/eji.70067","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T04:47:56Z","timestamp":1759812476000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Antigen\u2010Specific Tolerance: Clinical and Preclinical Approaches in Autoimmunity"],"prefix":"10.1002","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9654-5524","authenticated-orcid":false,"given":"Priscilla P. M.","family":"Faas","sequence":"first","affiliation":[{"name":"Division of Immunology Boston Children's Hospital  Boston Massachusetts USA"},{"name":"Department of Immunology Leiden University Medical Centre  Leiden the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5347-228X","authenticated-orcid":false,"given":"Stephanie D.","family":"Scharmann","sequence":"additional","affiliation":[{"name":"Division of Immunology Boston Children's Hospital  Boston Massachusetts USA"},{"name":"Institute of Innate Immunity Medical Faculty University of Bonn  Bonn Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Novalia","family":"Pishesha","sequence":"additional","affiliation":[{"name":"Division of Immunology Boston Children's Hospital  Boston Massachusetts USA"},{"name":"Department of Pediatrics Harvard Medical School  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600\u2010065X.2011.01019.x"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006957"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri3667"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.812774"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1084\/JEM.194.6.769"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00350"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature16962"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.MUCIMM.2023.05.006"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.06.023"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2023.01.004"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells10051190"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2017.09.003"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.12932\/AP0848"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.7680493"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/S001250051482"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(00)02579\u20104"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/immadv\/ltab017"},{"key":"e_1_2_12_19_1","unstructured":"\u201cA Phase III Study to Investigate If the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes \u201d ClinicalTrials.gov accessed February 23 2025 https:\/\/clinicaltrials.gov\/study\/NCT05018585?cond=T1D&term=antigen%20specific&sort=StudyFirstPostDate&aggFilters=status:not%20rec%20act&rank=2()."},{"key":"e_1_2_12_20_1","unstructured":"\u201cGAD\u2010Alum (Diamyd) Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes (DIAGNODE\u20101) \u201d ClinicalTrials.gov accessed March 25 2025 https:\/\/clinicaltrials.gov\/study\/NCT02352974?term=DIAGNODE&rank=1."},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.CCELL.2024.06.014\/ASSET\/86648C2F\u20104DDF\u20104F1E\u20109AA0\u20106069B79EC00A\/MAIN.ASSETS\/GR4_LRG.JPG"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.4049\/JIMMUNOL.1002961"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/NCOMMS12021"},{"key":"e_1_2_12_24_1","unstructured":"\u201cMER3101: MAS\u20101 Adjuvanted Antigen\u2010Specific Immunotherapeutic for Prevention and Treatment of Type 1 Diabetes \u201d ClinicalTrials.gov accessed February 23 2025 https:\/\/clinicaltrials.gov\/study\/NCT03624062?cond=T1D&term=antigen%20specific&sort=StudyFirstPostDate&aggFilters=status:not%20rec%20act&rank=7."},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.2337\/DB23\u20100996"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.SCIB.2024.02.042"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2016.09.007"},{"key":"e_1_2_12_28_1","unstructured":"\u201cAssessment of ANK\u2010700 in Patients With Relapsing Remitting Multiple Sclerosis \u201d ClinicalTrials.gov accessed February 23 2025 https:\/\/clinicaltrials.gov\/study\/NCT04602390?term=ANK\u2010700&rank=1."},{"key":"e_1_2_12_29_1","unstructured":"\u201cA Study of Efficacy Safety and Tolerability of KAN\u2010101 in People With Celiac Disease \u201d ClinicalTrials.gov accessed February 23 2025 https:\/\/clinicaltrials.gov\/study\/NCT06001177?term=KAN\u2010101&rank=1."},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41551\u2010023\u201001086\u20102"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468\u20101253(23)00107\u20103"},{"key":"e_1_2_12_32_1","unstructured":"\u201cA Study to Assess the Safety of TPM502 in Adults With Celiac Disease \u201d ClinicalTrials.gov accessed February 23 2025 https:\/\/clinicaltrials.gov\/study\/NCT05660109?term=Topas%20Therapeutics&rank=2."},{"key":"e_1_2_12_33_1","unstructured":"\u201cSingle Ascending Dose Study to Evaluate Safety Tolerability Pharmacokinetics and Pharmacodynamics of PVT201 in Healthy Subjects and Patients (PBC\/PSC) \u201dClinicalTrials.gov accessed February 23 2025 https:\/\/clinicaltrials.gov\/study\/NCT06798454?term=PVT201&rank=1."},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1021\/ACSAMI.4C00296"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.4.6.987"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/ADHM.202304238"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.BIOMATERIALS.2024.122943"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392\u2010022\u201001229\u2010y"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.1021\/ACSNANO.4C14698\/ASSET\/IMAGES\/LARGE\/NN4C14698_0005.JPEG"},{"key":"e_1_2_12_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/S41467\u2010022\u201035263\u20109"},{"key":"e_1_2_12_41_1","doi-asserted-by":"publisher","DOI":"10.1021\/ACSAMI.4C05428\/SUPPL_FILE\/AM4C05428_SI_002.MP4"},{"key":"e_1_2_12_42_1","doi-asserted-by":"publisher","DOI":"10.3390\/medicines12010004"},{"key":"e_1_2_12_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/SMLL.202307366"},{"key":"e_1_2_12_44_1","doi-asserted-by":"publisher","DOI":"10.26508\/LSA.202402996"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2024.1367514\/BIBTEX"},{"key":"e_1_2_12_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/ANIE.201509432"},{"key":"e_1_2_12_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41551\u2010021\u201000738\u20105"},{"key":"e_1_2_12_48_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12951\u2010024\u201002900\u2010y"},{"key":"e_1_2_12_49_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0805204105"},{"key":"e_1_2_12_50_1","doi-asserted-by":"publisher","DOI":"10.4049\/JIMMUNOL.1004175"},{"key":"e_1_2_12_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978\u20100\u201012\u2010386960\u20109.00003\u20104"},{"key":"e_1_2_12_52_1","unstructured":"\u201cA Clinical Trial Evaluating the Safety and Efficacy of Myelin\u2010Peptide Loaded TolDC As Treatment for MS \u201d ClinicalTrials.gov accessed March 24 2025 https:\/\/clinicaltrials.gov\/study\/NCT06715605?term=NCT06715605&rank=1."},{"key":"e_1_2_12_53_1","unstructured":"\u201cAn Immunotherapy Vaccine (PIpepTolDC) for the Treatment of Patients With Type 1 Diabetes \u201d ClinicalTrials.gov accessed March 24 2025 https:\/\/clinicaltrials.gov\/study\/NCT04590872?term=NCT04590872&rank=1."},{"key":"e_1_2_12_54_1","unstructured":"\u201cDendritic Cells Therapy Combined With Immunomodulatory Treatment in Multiple Sclerosis \u201d ClinicalTrials.gov accessed March 24 2025 https:\/\/clinicaltrials.gov\/study\/NCT04530318?term=NCT04530318&rank=1."},{"key":"e_1_2_12_55_1","unstructured":"\u201cAutologous 1 for Rheumatoid Arthritis (AutoDECRA) \u201d ClinicalTrials.gov accessed March 24 2025 https:\/\/clinicaltrials.gov\/study\/NCT01352858?term=NCT01352858&rank=1."},{"key":"e_1_2_12_56_1","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2300238"},{"key":"e_1_2_12_57_1","unstructured":"\u201cSafety Tolerability and Potential Efficacy of AVT001 in Patients With Type 1 Diabetes \u201d ClinicalTrials.gov accessed February 23 2025 https:\/\/clinicaltrials.gov\/study\/NCT03895996."},{"key":"e_1_2_12_58_1","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2024.1447897\/BIBTEX"},{"key":"e_1_2_12_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0300\u20109084(98)80024\u20102"},{"key":"e_1_2_12_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2012.12.044"},{"key":"e_1_2_12_61_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1701746114"},{"key":"e_1_2_12_62_1","unstructured":"\u201cPeptide\u2010Coupled Red Blood Cells for the Treatment of Multiple Sclerosis \u201d ClinicalTrials.gov accessed February 23 2025 https:\/\/clinicaltrials.gov\/study\/NCT06430671?cond=Multiple%20Sclerosis&term=antigen%20specific&aggFilters=status:not%20rec&rank=3."},{"key":"e_1_2_12_63_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1492552"},{"key":"e_1_2_12_64_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI.INSIGHT.171844"},{"key":"e_1_2_12_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41578\u2010021\u201000358\u20100"},{"key":"e_1_2_12_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.JCONREL.2024.09.020"},{"key":"e_1_2_12_67_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591\u2010022\u201002017\u20105"},{"key":"e_1_2_12_68_1","doi-asserted-by":"publisher","DOI":"10.1136\/ANNRHEUMDIS\u20102015\u2010208456"},{"key":"e_1_2_12_69_1","unstructured":"\u201cTolerogenic Dendritic Cell Therapy for Rheumatoid Arthritis \u201d ClinicalTrials.gov accessed March 24 2025 https:\/\/clinicaltrials.gov\/study\/NCT05251870?term=NCT05251870&rank=1."}],"container-title":["European Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/eji.70067","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:45:36Z","timestamp":1761547536000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/eji.70067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":68,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1002\/eji.70067"],"URL":"https:\/\/doi.org\/10.1002\/eji.70067","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.1002\/EJI.70067\/v3\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/EJI.70067\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/EJI.70067\/v2\/review3","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/EJI.70067\/v2\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/EJI.70067\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/EJI.70067\/v3\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/EJI.70067\/v1\/review3","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/EJI.70067\/v2\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/EJI.70067\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/EJI.70067\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/EJI.70067\/v2\/review1","asserted-by":"object"}]},"ISSN":["0014-2980","1521-4141"],"issn-type":[{"value":"0014-2980","type":"print"},{"value":"1521-4141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"2025-03-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70067"}}